FDA approved LEQEMBI IQLIK on July 13, 2026, a weekly at-home autoinjector for early Alzheimer’s patients. Here’s what it means and what patients should know.
FDA Approves Weekly At-Home Injection of Leqembi for Alzheimer’s Patients Starting Treatment
by | Jul 20, 2026 | Uncategorized | 0 comments
Recent Comments